Infant Formula and Toddler Drink Feeding Study

Inclusion Criteria:

• Participant is judged to be in good health as determined from participant's medicalhistory

• Participant is a singleton from a full-term birth with a gestational age of 37 - 42weeks by parent report

• Participant's birth weight was ≥ 2490 g (~5 lbs. 8 oz.)

• Parent(s) confirm their intention to feed their infant the study product as the solesource of feeding from Study Visit 1 to 6 months of age, and as the sole milkbeverage during the first 12 months of life

• Parent(s) confirm their intention to feed the infant the assigned toddler drink from 12 months of life to 24 months of life as the primary milk beverage

• Parent(s) confirm their intention not to administer vitamin or mineralsupplements,(except for vitamin D supplements if instructed by their healthcareprofessional) from enrollment through the duration of the study

• Parent(s) confirm their intention not to administer solid foods or juices to theinfant from enrollment through 6 months of age unless recommended by theparticipant's HCP

• Participant's parent(s) has voluntarily signed and dated an informed consent form (ICF), approved by an Institutional Review Board/Independent Ethics Committee (IRB/IEC) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation inthe study

• If parent(s) elect to feed the participant human milk, they confirm that theirinfant was fed human milk since birth and confirm their intention to exclusivelyfeed human milk as the sole source of feeding through 6 months of age.

• If parent(s) of human milk fed participant elect to supplement or wean, they confirmtheir intention to use the experimental supplemental/weaning formula andexperimental toddler drink as the primary milk beverage.

Exclusion Criteria:

• An adverse maternal, fetal or participant medical history that is thought by theinvestigator to have potential for effects on tolerance, growth, and/or development

• Awareness of a positive drug screen (including but not limited to cocaine, heroin,or methamphetamine) in the mother or participant

• Suspected maternal substance abuse including alcohol

• Participant is taking and plans to continue medications (including over the counter (OTC), such as Mylicon® for gas), home remedies (such as juice for constipation),herbal preparations, prebiotics or probiotics, or rehydration fluids that mightaffect GI tolerance

• Participant is in another study that has not been approved as a concomitant study byAN

• Participant has been treated with antibiotics (except for topical antibiotics, eyedrops) prior to enrollment

• Participant has been treated with other medications (besides antibiotics) that inthe opinion of the PI may affect growth, GI tolerance and/or development, prior toenrollment